From trial phases to personalized care, here’s how healthcare providers can navigate cancer clinical trials and guide ...

The new bill extends previous legislation, codifying how clinics can provide access to drugs that have only been through ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud.

From antibody-drug conjugates to PARP inhibitors, innovative treatments are offering new hope for patients with ...

While sparking excitement among biopharma companies focused on rare and ultrarare indications, experts say FDA Commissioner ...

The Food and Drug Administration's approval in 2023 of lecanemab—a novel Alzheimer's therapy shown in clinical ... In ...

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...

According to Makary and Prasad, the US’s adoption of a “one-size-fits-all” guidance for COVID-19 vaccination departs from ...

Delhi, May 15, 2025 (GLOBE NEWSWIRE) -- US Orphan Designated Drugs Market Opportunity, Drugs Sales, Price, Dosage and Clinical Trials Insight ... originally approved for rare types of Hodgkin ...

While the US Food and Drug Administration has been experiencing recent reorganization and cuts in personnel, the United ...

In a recent study, researchers found adverse events were rare and manageable among clinic patients with very mild or mild Alzheimer's disease who received lecanemab infusions.

(MENAFN- GlobeNewsWire - Nasdaq) Kuick Research Report Gives Detailed Insight On Ongoing Rare Disease Drug ... its clinical pipeline from rare epigenetic cancer targets and gained approval for ...